Research IPOs and Discover New Stocks
Aktis Oncology, a Phase 1 biotech developing targeted radiopharmaceuticals to treat solid tumors, raised $318 million by offering 17.7 million shares at $18, the high end of the range of $16 to $18. The company originally planned to offer 11.8 million shares at ...read more
Cantor Equity Partners VI, the fifteenth blank check company formed by Cantor Fitzgerald, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The company plans to raise $100 million by offering 10 million shares at $10....read more
Bleichroeder Acquisition II, a blank check company led by investment veterans targeting technology, raised $250 million by offering 25 million units at $10.00. Each unit consists of one share of common stock and one-third of one warrant, exercisable at $11.50. ...read more
| Ticker | Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology | AKTS | 00/00/00 | 17.7 | $16.00 - $18.00 | $318 | JP Morgan BofA |
| LBRJ | Libera Gaming Operations | LBRJ | 00/00/00 | 1.3 | $4.00 - $6.00 | $6 | D. Boral Capital Sutter Securities |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Ticker | Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology | AKTS | 01/08/26 | $318 | $18.00 |
n/a
n/a
|
n/a |
| BUDA | Buda Juice | BUDA | 01/07/26 | $20 | $8.11 |
$0.00
(0.0%)
|
8.1% |
| ANDG | Andersen Group | ANDG | 12/16/25 | $176 | $24.25 |
$0.00
(0.0%)
|
51.6% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Preview
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
